Clinical Trials Logo

Attention Deficit Disorder clinical trials

View clinical trials related to Attention Deficit Disorder.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06064942 Completed - Clinical trials for Attention-deficit/Hyperactivity Disorder

Multiple Family Narrative Therapy for Chinese Families of Children With Attention Deficit Hyperactivity Disorder

MFNT-CADHD
Start date: September 1, 2022
Phase: N/A
Study type: Interventional

The goal of this randomized controlled trial is to develop and to implement a multiple family narrative therapy intervention consisting of parent-child relationships training among Chinese families of children with attention deficit hyperactivity disorder (ADHD). The intervention aims to reduce the psychological distress of parents and their child, thus improving parent-child relationships, and the trial aims to assess the effectiveness of MFNT among them. A RCT design supplemented by qualitative interviews will be used to evaluate the effectiveness of multiple family narrative therapy intervention on family welfare.

NCT ID: NCT06030024 Completed - ADHD Clinical Trials

Efficacy of Repetitive Transcranial Magnetic Stimulation in Adult Attention Deficit Disorder

Start date: September 1, 2021
Phase: N/A
Study type: Interventional

The purpose of the current open-lable study was to use low-frequency repetitive transcranial magnetic stimulation (rTMS) to improve the attention deficits in a sample of adult patients suffering from attention deficit disorder. Participants received 10 sessions of rTMS over Fz (located using the EEG 10-20 international system) and underwent assessments of their attentional capacity using the gradCPT task in an fMRI scanner, before and after the intervention. Other behavioral assessments of their attention symptoms have also been conducted.

NCT ID: NCT05200936 Completed - ADHD Clinical Trials

Safety and Efficacy of Low Dose MM-120 for ADHD Proof of Concept Trial

Start date: December 17, 2021
Phase: Phase 2
Study type: Interventional

This study measures the safety and efficacy of repeated low dose MM-120 as treatment for ADHD in adults: a multi-center, randomized, double-blind, placebo-controlled

NCT ID: NCT05096975 Completed - Clinical trials for Attention Deficit Disorder

Personality Profile of Children and Adolescents With ADHD and With or Without Emotional Dysregulation

Start date: September 1, 2020
Phase:
Study type: Observational

Attention Deficit Hyperactivity Disorder (ADHD) is frequently associated with emotional dysregulation (ED). ED is characterized by excessive and inappropriate emotional reactions compared to social norms, uncontrolled and rapide shifts in emotion and attention focused on emotional stimuli. According to research, there are strong correlations between personality traits and psychiatric disorder as ADHD. In a longitudinal study, the persistence of ADHD symptoms during adolescence is associated with high neuroticism, low agreeableness and low conscience. Studies show that these personality traits are factors of vulnerabilities for comordities associated with ADHD and are predictive of overall functioning difficulties. Studies show correlations between ADHD in childhood and personality disorders at adulthood . ADHD is frequently associated with emotional dysregulation (ED) that is characterized by an inability to modulate emotional responses in a given context . ED is observed in 24% to 50% children with ADHD . Children with ADHD and ED are more likely to present a severe and complex symptomatology and are at risk for antisocial and bordeline personality disorders than children without ED. To date, there would be no studies which would have been interested in personality traits in children with ADHD and ED. The main objective is to determine if children with ADHD and ED present from childhood traits of personality as low agreeableness, low conscience and high neuroticism that are predictive of personality disorders at adulthood. It would involve earl identification of children at increased risk of pejorative developmental trajectories. The second objectives are: - Improve understanding of the heterogeneity of ADHD symptom expression; - Have a better understanding of the child's personalit and temperament traits to identify riks and protective factors; - Identify children with ADHD with profiles at risk of personality disorders in order to adapt the care according to the child's needs.

NCT ID: NCT04577417 Completed - Clinical trials for Attention Deficit Hyperactivity Disorder

Stimulant Medication Effects on Auditory Sensitivity in Teens With ADHD

Start date: September 13, 2020
Phase:
Study type: Observational

The aims of this study are to evaluate auditory sensitivity in teenagers with ADHD using acoustic reflex thresholds (ART) and to examine the effects of ADHD stimulant medication on ART.

NCT ID: NCT03949413 Completed - Clinical trials for Attention Deficit Disorder

Correlation Between Balance and Attention in Children With Attention Deficit Hyperactivity Disorder

Start date: February 1, 2019
Phase:
Study type: Observational

Objective: The purpose of the current study was to investigate balance in children with attention deficit hyperactivity disorder compared to normal subjects. Furthermore, it studied the relationship between their balance and the total percentile scores of the ADHD Rating Scale IV.

NCT ID: NCT03948607 Completed - Clinical trials for Attention Deficit Disorder

Neural Mechanisms of Attention Lapses in Adult ADHD

AttLapse-TDA
Start date: September 10, 2019
Phase:
Study type: Observational

ADHD is a common disorder, leading to a significant disability that often persists in adulthood. ADHD is characterized by attentional disturbances that are difficult to asses with standard neuropsychological tests. Attention tends to stall after a certain time of fatigue (i.e. an attention lapse). The aim of this study is to study the electroencephalographic (EEG) characteristics of these attention lapses in a sustained attention task, comparing ADHD patients with healthy subjects.

NCT ID: NCT03852966 Completed - Clinical trials for Sleep Initiation and Maintenance Disorders

Better Sleep in Psychiatric Care - ADHD Pilot Study

BeSiP-ADHD
Start date: September 1, 2015
Phase: N/A
Study type: Interventional

Comorbidities, including sleep problems, are common in adult Attention Deficit Hyperactivity Disorder (ADHD). Treatment of choice for insomnia is cognitive behavioral therapy (CBT-i), but evidence is lacking for CBT-i in patients with ADHD and sleep problems. The purpose of this study was to investigate if patients at a specialist clinic for ADHD benefit from a group delivered CBT-i treatment; whether insomnia severity improves following this treatment. This pragmatic within-group pilot study with a pre to post and three-month follow-up design was set at a specialist psychiatric out-patient clinic for adult ADHD. As an adjunct to care-as-usual at the clinic, a CBT-i-based group treatment targeting sleep problems prevalent in the ADHD-population, designed for patients with executive difficulties, was offered as 10 weekly 90-minute group sessions and scheduled telephone support. All outcome measures were subjectively reported by participants. Data analyzed with dependent t-tests according to intent-to-treat.

NCT ID: NCT03662763 Completed - Clinical trials for Attention Deficit Disorder

Extended-release Guanfacine Hydrochloride in Children/Adolescents With Attention-deficit/Hyperactivity

SPD503-315
Start date: September 2011
Phase: Phase 3
Study type: Interventional

A study to evaluate the long term maintenance of efficacy of using Guanfacine Hydrochloride (SPD-503) for the treatment of ADHD in Children aged 6-17 years in Europe, Australia, Canada and the US.

NCT ID: NCT03605849 Completed - Clinical trials for Attention Deficit Hyperactivity Disorder

A Trial Evaluating the Long-term Safety and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder

Start date: February 14, 2019
Phase: Phase 3
Study type: Interventional

This study will evaluate the long-term safety and tolerability of centanafadine sustained-release tablets, administered twice daily in the treatment of adults with attention deficit hyperactivity disorder (ADHD).